Safety Study of ME-609 for Treatment of Herpes Simplex Labialis in Adolescents

• Status: Completed
• Trial end date: 2007-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The Purpose of this study is to evaluate the safety of ME-609 for the treatment of recurrent herpes labialis in adolescents.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Medivir

Criteria

Inclusion Criteria:

• General good health

• History of recurrent herpes labialis with at two recurrences during the last twelve months

Exclusion Criteria:

• Treatment with systemic or topical antiviral agents or steroids within two weeks prior to inclusion

• Significant skin condition that occur in the area of herpes recurrences

• Nursing or/and pregnancy

• Immunosupressed state due to underlying disease (e.g. HIV infection or concomitant treatment (e.g. cancer chemotherapy)